Recent Updates — TMO

Thermo Fisher Scientific Inc. announced that Executive Vice President Michael D. Shafer will retire from his position effective December 31, 2026. The company operates in the scientific instruments and laboratory equipment industry.

Thermo Fisher Scientific reported third-quarter 2026 financial results with revenue growing 9% to $12.14 billion, driven by a 6% increase in organic sales. GAAP diluted earnings per share rose 9% to $4.64, while adjusted EPS increased 15% to $6.68. The company also completed the previously announced divestiture of its microbiology business during the quarter and highlighted new product launches including the Orbitrap Isora mass spectrometer and FDA-cleared EliA CTD 13 Screen. Thermo Fisher Scientific Inc. is a global leader in serving science, providing analytical instruments, lab equipment, reagents, software, and services to life sciences research, healthcare, and industrial sectors.

Thermo Fisher Scientific reported second quarter 2026 financial results for the period ended June 27, 2026. Revenue increased 10% to $11.99 billion, representing 5% organic growth. GAAP diluted earnings per share grew 9% to $4.68, while adjusted EPS rose 13% to $6.03. The company reported GAAP operating income of $2.09 billion and adjusted operating income of $2.73 billion. During the quarter, the company announced the divestiture of its microbiology business and repurchased $1.0 billion of stock. Thermo Fisher Scientific is a global provider of scientific instrumentation, analytical instruments, and laboratory solutions.